| abstract |
The invention concerns human hepatoma cell lines, characterised in that they are capable of being naturally infected by parasites and/or viruses; said parasites can be hepatotropic or not, such as <i>Plasmodium</i> or <i>parasites of the genus leishmania</i> and express receptors of the family of <i>Flaviviridae</i> and <i>Hepadnaviridae</i> viruses, preferably HBV and HCV. The invention has diagnostic, therapeutic and prophylactic applications. |